- ICH GCP
- US Clinical Trials Registry
- Search trials
Clinical Trials on Human Blood Cell Disorders in United States
Total 18826 results
-
Northwell HealthRecruitingHuman Blood Cell Disorders | Lymphoid, Myeloid and Erythroid Proliferative DiseaseUnited States
-
Boston VA Research Institute, Inc.Dana-Farber Cancer InstituteCompletedPlasma Cell DisorderUnited States
-
Jonsson Comprehensive Cancer CenterNovartis PharmaceuticalsWithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | HLA-A*0201 Positive Cells Present | NY-ESO-1 Positive Tumor Cells PresentUnited States
-
National Cancer Institute (NCI)CompletedHuman T-Lymphoma Virus Type IUnited States, Jamaica, Japan
-
Indiana UniversityCompletedHuman Papilloma Virus Vaccine HesitancyUnited States
-
Duke UniversityNational Institutes of Health (NIH); National Institute on Aging (NIA)WithdrawnAutophagy and Apoptosis in Human Satellite CellsUnited States
-
University of Alabama at BirminghamTerminatedMultiple Myeloma | Mantle Cell Lymphoma | Non Hodgkin's Lymphoma | CLL / SLL | WaldenstromsUnited States
-
Becton, Dickinson and CompanyCompletedPlasma Cell DisorderSwitzerland, Spain, United Kingdom, United States, Portugal
-
Pamela MunsterNovartisWithdrawnLocally Advanced Malignant Solid Neoplasm | Metastatic Malignant Solid Neoplasm | Solid Tumors, Adult | HPV-Related Squamous Cell Carcinoma | Human Papillomavirus-Related Carcinoma | PIK3CA Mutation-Related Tumors | PIK3CA Mutation | Human Papillomavirus-Related Squamous Cell CarcinomaUnited States
-
Yale UniversityCompletedMultiple Myeloma | Influenza | Waldenstrom's Macroglobulinemia | MGUS | Plasma Cell DisordersUnited States
-
University of FloridaWakunaga Pharmaceutical Co., Ltd.CompletedImprovement in Immune Cell Function in Healthy HumansUnited States
-
University of FloridaKyowa Hakko Bio Co., Ltd.CompletedImprovement in Immune Cell Function in Elderly HumansUnited States
-
National Institute of Allergy and Infectious Diseases...Completed
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedHepatitis | Safety and TolerabilityUnited States
-
Gilead SciencesCompletedLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Non-Hodgkin | Lymphoma, Low-Grade | Lymphoma, Small Lymphocytic | Leukemia, Prolymphocytic | NHL | CLL | Leukemia, Lymphocytic, Chronic | Lymphoma, Intermediate-Grade | Lymphoma, Large-Cell | Lymphoma, Mixed-Cell | Lymphoma, Small-Cell | Leukemia, B-Cell, Chronic | Leukemia... and other conditionsUnited States
-
University of WashingtonNational Cancer Institute (NCI)WithdrawnAnaplastic Large Cell Lymphoma, ALK-Positive | CD30-Positive Neoplastic Cells Present | Systemic Anaplastic Large Cell LymphomaUnited States
-
Mayo ClinicArizona State UniversityCompletedMultiple Myeloma | Plasma Cell DisorderUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingRefractory Plasma Cell Myeloma | Plasmacytoma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
University of RochesterTerminatedLymphoma, Follicular | Waldenstrom Macroglobulinemia | T-Cell Lymphoma | Chronic Lymphocytic Leukemia (CLL) | Small Lymphocytic Lymphoma | Adult Diffuse Large B-Cell Lymphoma | Mantle Cell Lymphoma Recurrent | Marginal Zone B-Cell Lymphoma | Malignant Lymphoma - LymphoplasmacyticUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)Active, not recruitingPlasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)WithdrawnPlasma Cell Myeloma | Plasma Cell Leukemia in RemissionUnited States
-
Sidney Kimmel Comprehensive Cancer Center at Johns...Novartis PharmaceuticalsCompletedMantle Cell Lymphoma | Gray Zone Lymphoma | Hodgkin's Disease | CD20+, B-cell Lymphomas | Non-Mantle Cell Low Grade B Cell Lymphomas (SLL/CLL) | Transformed Lymphoma/DLBCL/PMBCLUnited States
-
National Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Plasma Cell LeukemiaUnited States
-
Masonic Cancer Center, University of MinnesotaTerminatedLymphoma | Leukemia | Multiple Myeloma and Plasma Cell Neoplasm | Germ Cell TumorUnited States
-
Newave Pharmaceutical IncRecruitingFollicular Lymphoma | Waldenstrom Macroglobulinemia | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Diffuse Large B Cell Lymphoma | Hairy Cell Leukemia | CLL/SLLUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedHematopoietic and Lymphoid Cell Neoplasm | Lymphoma | Leukemia | Plasma Cell Myeloma | B-Cell Non-Hodgkin Lymphoma | T-Cell Non-Hodgkin LymphomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Fred Hutchinson Cancer CenterNational Cancer Institute (NCI); Juno Therapeutics, Inc.CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Yvonne EfeberaBristol-Myers Squibb; National Cancer Institute (NCI); American Cancer Society...TerminatedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
Ohio State University Comprehensive Cancer CenterNational Cancer Institute (NCI)WithdrawnRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Hematopoietic Cell Transplantation RecipientUnited States
-
Emory UniversityNational Cancer Institute (NCI); Merck Sharp & Dohme LLC; National Institutes...CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | ISS Stage III Plasma Cell Myeloma | ISS Stage II Plasma Cell Myeloma | ISS Stage I Plasma Cell MyelomaUnited States
-
National Heart, Lung, and Blood Institute (NHLBI)CompletedMultiple Myeloma | Waldenstrom Macroglobulinemia | Leukemia, Lymphocytic, Chronic, B-Cell | Leukemia, Hairy Cell | Lymphoma, Mantle-cellUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingLymphoma | Lymphoma, B-Cell | Multiple Myeloma | High-grade B-cell Lymphoma | Refractory B-Cell Lymphoma | DLBCL NOSUnited States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell Myeloma | Non-Secretory Plasma Cell Myeloma | PlasmacytosisUnited States
-
Steven E. CoutreBayerCompletedLeukemia | Chronic Lymphocytic Leukemia (CLL) | Chronic Leukemia | B-cell LeukemiaUnited States
-
M.D. Anderson Cancer CenterRecruitingHuman Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-TypeUnited States
-
Baylor College of MedicineNational Cancer Institute (NCI)CompletedDiffuse Large B Cell Lymphoma | Post Transplant Lymphoproliferative Disorder | Primary Mediastinal (Thymic) Large B-cell LymphomaUnited States
-
Mayo ClinicNational Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
National Cancer Institute (NCI)CompletedRefractory Plasma Cell Myeloma | DS Stage I Plasma Cell Myeloma | DS Stage II Plasma Cell Myeloma | DS Stage III Plasma Cell MyelomaUnited States
-
Tufts Medical CenterBoston Medical Center; Northeastern UniversityNot yet recruitingHuman Papilloma VirusUnited States
-
Mayo ClinicRecruitingOropharyngeal Human Papillomavirus-Positive Squamous Cell CarcinomaUnited States
-
Brittany RosenNational Cancer Institute (NCI)CompletedHuman Papilloma VirusUnited States
-
University of FloridaCompletedHuman Papilloma VirusUnited States
-
MEE Productions, Inc.Thomas Jefferson UniversityCompletedHuman Papilloma VirusUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI)RecruitingRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States
-
University of Southern CaliforniaNational Cancer Institute (NCI); Oncolytics BiotechCompletedRefractory Plasma Cell Myeloma | Recurrent Plasma Cell MyelomaUnited States